Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
72,000
Employees72,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
72,000
Employees72,000

BDX Key Statistics

Market cap
56.04B
Market cap56.04B
Price-Earnings ratio
34.40
Price-Earnings ratio34.40
Dividend yield
2.08%
Dividend yield2.08%
Average volume
2.05M
Average volume2.05M
High today
$200.81
High today$200.81
Low today
$195.12
Low today$195.12
Open price
$200.01
Open price$200.01
Volume
2.38M
Volume2.38M
52 Week high
$251.99
52 Week high$251.99
52 Week low
$162.29
52 Week low$162.29

Stock Snapshot

As of today, Becton Dickinson(BDX) shares are valued at $196.39. The company's market cap stands at 56.04B, with a P/E ratio of 34.40 and a dividend yield of 2.1%.

On 2025-12-16, Becton Dickinson(BDX) stock traded between a low of $195.12 and a high of $200.81. Shares are currently priced at $196.39, which is +0.7% above the low and -2.2% below the high.

The Becton Dickinson(BDX)'s current trading volume is 2.38M, compared to an average daily volume of 2.05M.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

During the past year, Becton Dickinson(BDX) stock moved between $162.29 at its lowest and $251.99 at its peak.

BDX News

Nasdaq 14h
These Surging Divvies Are the Next AI Winners (Wall Street Hates Them)

Today I have a sweet dividend "double shot" for you: The first? A 2.8% payout set to grow thanks to AI--and take the stock price up with it. The second gives y...

These Surging Divvies Are the Next AI Winners (Wall Street Hates Them)
Simply Wall St 3d
Becton Dickinson: Valuation Check After New Cell Analyzers Launch and ChemoGLO Safety Alliance

Recent moves in Becton Dickinson (BDX) have been driven by two MedTech updates: a global rollout of next generation cell analyzers and a new ChemoGLO alliance f...

Becton Dickinson: Valuation Check After New Cell Analyzers Launch and ChemoGLO Safety Alliance
Nasdaq 5d
Becton, Dickinson Reaches Analyst Target Price

In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $2...

Becton, Dickinson Reaches Analyst Target Price

Analyst ratings

67%

of 15 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.